Table 2. Pearson correlation coefficients between DNA methylation and mRNA levels at LEP gene promoter CpG sites in subcutaneous (SAT) and visceral adipose (VAT) tissues according to rs2167270 genotype and adjusted for sex.
SAT | VAT | |||||
---|---|---|---|---|---|---|
ALLa | GGa | GA/AAa | ALLa | GGa | GA/AAa | |
n | 73 | 30 | 43 | 73 | 30 | 43 |
LEP-CpG3 | −0.079 | 0.145 | −0.215 | 0.070 | 0.286 | −0.068 |
LEP-CpG4 | −0.093 | 0.243 | −0.294† | 0.201 | 0.266 | 0.194 |
LEP-CpG5 | −0.060 | 0.318† | −0.300† | 0.173 | 0.294 | 0.061 |
LEP-CpG6 | −0.051 | 0.267 | −0.239 | 0.211† | 0.350† | 0.093 |
LEP-CpG7 | −0.076 | 0.228 | −0.249 | 0.320* | 0.575** | 0.139 |
LEP-CpG11 | −0.056 | 0.018 | −0.070 | 0.290* | 0.390* | 0.238 |
LEP-CpG12 | −0.124 | 0.004 | −0.239 | 0.086 | 0.281 | −0.039 |
LEP-CpG13 | −0.057 | 0.192 | −0.206 | 0.308* | 0.627** | 0.125 |
LEP-CpG14 | −0.126 | 0.324† | −0.497** | 0.222† | 0.322† | 0.147 |
LEP-CpG15 | −0.065 | 0.328† | −0.285† | 0.180 | 0.281 | 0.097 |
LEP-CpG16 | −0.093 | 0.031 | −0.173 | 0.125 | 0.371* | 0.003 |
LEP-CpG17 | −0.172 | 0.078 | −0.367* | 0.103 | 0.212 | 0.014 |
LEP-CpG23 | −0.168 | 0.083 | −0.340* | 0.225† | 0.200 | 0.256 |
LEP-CpG24 | −0.134 | 0.202 | −0.333* | 0.114 | 0.117 | 0.116 |
LEP-CpG25 | −0.093 | 0.329† | −0.345* | 0.193 | 0.152 | 0.207 |
LEP-CpG26 | 0.048 | 0.395* | −0.194 | 0.268* | 0.282 | 0.264 |
LEP-CpG27 | 0.006 | 0.315 | −0.238 | 0.301* | 0.250 | 0.352 |
LEP-CpG28 | −0.012 | 0.069 | −0.090 | 0.265* | 0.351† | 0.180 |
LEP-CpG29 | −0.036 | 0.203 | −0.217 | 0.252* | 0.175 | 0.322 |
LEP-CpG30 | −0.094 | 0.117 | −0.233 | 0.215* | 0.239 | 0.212 |
LEP-CpG31 | −0.068 | 0.079 | −0.188 | 0.172 | 0.317† | 0.102 |
LEP-MEAN | −0.060 | 0.268 | −0.265† | 0.297* | 0.372* | 0.241 |
a Adjusted for sex. Statistically significant: **P ≤ 0.05 after corrections for multiple testing; *P ≤ 0.05 and †P ≤ 0.10 without correction for multiple testing.